Ladenburg Thalmann Financial Services’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,583
Closed -$3.86M 5333
2017
Q4
$3.86M Sell
6,583
-683
-9% -$441K 0.04% 435
2017
Q3
$5.36M Buy
7,266
+245
+3% +$203K 0.06% 294
2017
Q2
$6.09M Buy
7,021
+489
+7% +$410K 0.07% 254
2017
Q1
$5.54M Buy
6,532
+212
+3% +$176K 0.07% 250
2016
Q4
$4.82M Buy
6,320
+1,798
+40% +$1.36M 0.07% 259
2016
Q3
$3.71M Buy
4,522
+1,285
+40% +$1.11M 0.06% 308
2016
Q2
$2.7M Buy
+3,237
New +$2.7M 0.04% 365

Other funds holding AGN.PRA

Ladenburg Thalmann Financial Services's AGN.PRA Position: Q1 2018 in Review

Ladenburg Thalmann Financial Services sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 6,583 shares — an estimated $3.86M sold.

Ladenburg Thalmann Financial Services first reported a position in AGN.PRA in Q2 2016 and held it in 7 quarters. The position peaked at $6.09M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Ladenburg Thalmann Financial Services reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 6,583 Allergan plc shares in Q1 2018, an estimated $3.86M.
  • Ladenburg Thalmann Financial Services first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
  • Ladenburg Thalmann Financial Services's Allergan plc position peaked at $6.09M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2018, filed 15 May 2018.